Explain this page
Arphra AIPlain-English read on United Therapeutics Corporation’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $636.83 (+16.24%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.58% | -0.29% | -3.02% | +3.53% | +15.01% | +12.44% | +66.83% | +139.78% | +213.51% | +384.28% | +8890.61% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$2.47M
10 txns
Net flow
−$2.47M
Aftermarket
LiveLast trade
$547.87
14 sh
Bid
$546.91
94 sh
Ask
$548.82
18 sh
Spread
$1.910
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Consumer Cyclical+1.35%
- Real Estate+1.13%
- Industrials+1.13%
- Utilities+0.78%
- Communication Services+0.63%
- Basic Materials+0.51%
- Financial Services+0.45%
- Consumer Defensive+0.27%
- Technology+0.13%
- Healthcare-0.32%
- Energy-0.76%
Top industries (issuer's industry highlighted)
- Biotechnology+1.15%
- Furnishings, Fixtures & Appliances+5.01%
- Solar-4.31%
- Financial - Mortgages+4.06%
- Investment - Banking & Investment Services-4.02%
- Apparel - Manufacturers+3.72%
- Electronic Gaming & Multimedia+3.71%
- Medical - Healthcare Information Services+3.50%
- Medical - Equipment & Services+3.36%
- Apparel - Footwear & Accessories+3.21%
- REIT - Office+3.10%
- Home Improvement+3.09%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?zacks.com·Jun 05, 2026
- United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
- United Therapeutics Corporation Reports First Quarter 2026 Financial Resultsbusinesswire.com·May 06, 2026
- Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?zacks.com·May 04, 2026
Peers
No peer list available for UTHR.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
ROTHBLATT MARTINE A director, officer: Chairperson & CEO | Sell | 56 | $32.67K | May 12, 2026 |
ROTHBLATT MARTINE A director, officer: Chairperson & CEO | Sell | 106 | $60.6K | May 12, 2026 |
ROTHBLATT MARTINE A director, officer: Chairperson & CEO | Sell | 240 | $136.52K | May 12, 2026 |
ROTHBLATT MARTINE A director, officer: Chairperson & CEO | Sell | 293 | $167.92K | May 12, 2026 |
ROTHBLATT MARTINE A director, officer: Chairperson & CEO | Sell | 400 | $228.13K | May 12, 2026 |
ROTHBLATT MARTINE A director, officer: Chairperson & CEO | Sell | 401 | $230.05K | May 12, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|